JPRN-jRCT2080223889已完成3 期
A phase III study of JR-401 in short stature patients with SHOX deficiency
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 3age old 至 <= 9age old（—）
- 性别
- All
入选标准
- •1.The children have a diagnosis of SHOX deficiency by geneanalysis.
- •2.A girl patients who is clearly not a Turner syndrome base on chromosome testing.
排除标准
- •Pediatric patients who have received continuous GH treatment.
- •Pediatric patients who have received any treatment that may have effect on the growth stimulation.
- •Pediatric patients with a disease that causes a short stature unrelated to SHOX deficiency.
- •Pediatric patients with diagnosis of Langer type middle limb bone dysplasia.
研究者
相似试验
进行中（未招募）
不适用
An extention study of JR-401 in patients with SHOX dificiencySHOX deficiencyJPRN-jRCT2031200425Ibaraki Ryo19
已完成
1 期
A Phase I/II study of JR-031 for the patients of standard primary treatment-refractory acute graft-versus-host disease (acute GVHD) after hematopoietic stem cell transplantatioStandard primary treatment-refractory acute GVHDJPRN-UMIN000001716JCR pharmaceuticals Co.,Ltd20
已完成
2 期
A Phase II/III trial of JR-031 for the treatment of steroid-refractory acute Graft-versus-Host disease after hematopoietic stem cell transplantioSteroid-refractory acute Graft-versus-Host diseaseJPRN-UMIN000006719JCR pharmaceuticals Co., Ltd.25
招募中
1 期
Phase I/II study of weekly infusions of JR-441 in patients with mucopolysaccharidosis type IIIA2024-517045-14-00Jcr Pharmaceuticals Co. Ltd.22
进行中（未招募）
1 期
An Extension Study of JR-171-101 Study in Patients With Mucopolysaccharidosis Type IMucopolysaccharidosis IJPRN-jRCT2051210040Kawashima Satoshi14